These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 22196370)

  • 1. Dual or triple activation of TLR7, TLR8, and/or TLR9 by single-stranded oligoribonucleotides.
    Forsbach A; Samulowitz U; Völp K; Hofmann HP; Noll B; Tluk S; Schmitz C; Wader T; Müller C; Podszuweit A; Lohner A; Curdt R; Uhlmann E; Vollmer J
    Nucleic Acid Ther; 2011 Dec; 21(6):423-36. PubMed ID: 22196370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of RNA sequence motifs stimulating sequence-specific TLR8-dependent immune responses.
    Forsbach A; Nemorin JG; Montino C; Müller C; Samulowitz U; Vicari AP; Jurk M; Mutwiri GK; Krieg AM; Lipford GB; Vollmer J
    J Immunol; 2008 Mar; 180(6):3729-38. PubMed ID: 18322178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligodeoxynucleotides differentially modulate activation of TLR7 and TLR8 by imidazoquinolines.
    Gorden KK; Qiu X; Battiste JJ; Wightman PP; Vasilakos JP; Alkan SS
    J Immunol; 2006 Dec; 177(11):8164-70. PubMed ID: 17114492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.
    Domingues R; de Carvalho GC; da Silva Oliveira LM; Futata Taniguchi E; Zimbres JM; Aoki V; da Silva Duarte AJ; Sato MN
    Br J Dermatol; 2015 Jan; 172(1):48-55. PubMed ID: 24976336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate immunity at the mucosal surface: role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens.
    Andersen JM; Al-Khairy D; Ingalls RR
    Biol Reprod; 2006 May; 74(5):824-31. PubMed ID: 16421230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and immunological activities of novel Toll-like receptor 7 and 8 agonists.
    Kandimalla ER; Struthers M; Bett AJ; Wisniewski T; Dubey SA; Jiang W; Precopio M; Sun Z; Wang H; Lan T; Agrawal S; Casimiro DR
    Cell Immunol; 2011; 270(2):126-34. PubMed ID: 21570062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA recognition via TLR7 and TLR8.
    Hornung V; Barchet W; Schlee M; Hartmann G
    Handb Exp Pharmacol; 2008; (183):71-86. PubMed ID: 18071655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunostimulatory potential of silencing RNAs can be mediated by a non-uridine-rich toll-like receptor 7 motif.
    Jurk M; Chikh G; Schulte B; Kritzler A; Richardt-Pargmann D; Lampron C; Luu R; Krieg AM; Vicari AP; Vollmer J
    Nucleic Acid Ther; 2011 Jun; 21(3):201-14. PubMed ID: 21749297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic oligoribonucleotides-containing secondary structures act as agonists of Toll-like receptors 7 and 8.
    Lan T; Putta MR; Wang D; Dai M; Yu D; Kandimalla ER; Agrawal S
    Biochem Biophys Res Commun; 2009 Aug; 386(3):443-8. PubMed ID: 19523922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD14+ cells are required for IL-12 response in bovine blood mononuclear cells activated with Toll-like receptor (TLR) 7 and TLR8 ligands.
    Buza J; Benjamin P; Zhu J; Wilson HL; Lipford G; Krieg AM; Babiuk LA; Mutwiri GK
    Vet Immunol Immunopathol; 2008 Dec; 126(3-4):273-82. PubMed ID: 18789542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA-Cholesterol Nanoparticles Function as Potent Immune Activators
    Obermann HL; Lederbogen II; Steele J; Dorna J; Sander LE; Engelhardt K; Bakowsky U; Kaufmann A; Bauer S
    Front Immunol; 2021; 12():658895. PubMed ID: 35126343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of molecular structure and delivery of RNA oligonucleotides to activate TLR7 versus TLR8 and to induce high amounts of IL-12p70 in primary human monocytes.
    Ablasser A; Poeck H; Anz D; Berger M; Schlee M; Kim S; Bourquin C; Goutagny N; Jiang Z; Fitzgerald KA; Rothenfusser S; Endres S; Hartmann G; Hornung V
    J Immunol; 2009 Jun; 182(11):6824-33. PubMed ID: 19454678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity and immune response induction of a dual agonist of Toll-like receptors 7 and 8.
    Wang D; Precopio M; Lan T; Yu D; Tang JX; Kandimalla ER; Agrawal S
    Mol Cancer Ther; 2010 Jun; 9(6):1788-97. PubMed ID: 20515950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLR7/8 agonists activate a mild immune response in rabbits through TLR8 but not TLR7.
    Lai CY; Liu YL; Yu GY; Maa MC; Leu TH; Xu C; Luo Y; Xiang R; Chuang TH
    Vaccine; 2014 Sep; 32(43):5593-9. PubMed ID: 25131730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor 7 selective synthetic oligoribonucleotide agonists: synthesis and structure-activity relationship studies.
    Lan T; Dai M; Wang D; Zhu FG; Kandimalla ER; Agrawal S
    J Med Chem; 2009 Nov; 52(21):6871-9. PubMed ID: 19824640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8.
    Heil F; Hemmi H; Hochrein H; Ampenberger F; Kirschning C; Akira S; Lipford G; Wagner H; Bauer S
    Science; 2004 Mar; 303(5663):1526-9. PubMed ID: 14976262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guanine-modified inhibitory oligonucleotides efficiently impair TLR7- and TLR9-mediated immune responses of human immune cells.
    Römmler F; Hammel M; Waldhuber A; Müller T; Jurk M; Uhlmann E; Wagner H; Vollmer J; Miethke T
    PLoS One; 2015; 10(2):e0116703. PubMed ID: 25695778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokine, cytokine and type I interferon production induced by Toll-like receptor activation in common variable immune deficiency.
    Lollo C; de Moraes Vasconcelos D; Oliveira LMDS; Domingues R; Carvalho GC; Duarte AJDS; Sato MN
    Clin Immunol; 2016 Aug; 169():121-127. PubMed ID: 27392462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic oligoribonucleotides containing arabinonucleotides act as agonists of TLR7 and 8.
    Lan T; Bhagat L; Wang D; Dai M; Kandimalla ER; Agrawal S
    Bioorg Med Chem Lett; 2009 Apr; 19(7):2044-7. PubMed ID: 19269175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of human B cell activation by TLR7 and TLR9 agonists.
    Hanten JA; Vasilakos JP; Riter CL; Neys L; Lipson KE; Alkan SS; Birmachu W
    BMC Immunol; 2008 Jul; 9():39. PubMed ID: 18652679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.